VIGIL NEUROSCIENCE, INC.

Analyst Reco. Vigil Neuroscience, Inc.

Equities

VIGL

US92673K1088

Market Closed - Nasdaq Other stock markets 21:00:00 07/05/2024 BST			5-day change	1st Jan Change
3.19 ^USD	+10.38%		+22.22%	-5.62%

05-07	Vigil Neuroscience, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
04-17	Vigil Neuroscience, Inc. Presents Key Findings from Illuminate & Ignite Studies in ALSP At the 2024 American Academy of Neurology Annual Meeting	CI

Analyst Reco.

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Wedbush Trims Vigil Neuroscience Price Target to $22 From $23, Maintains Outperform Rating	03-26	MT
Morgan Stanley Downgrades Vigil Neuroscience to Underweight From Equalweight, Cuts Price Target to $4 From $13	12-19	MT
JMP Securities Starts Vigil Neuroscience With Market Outperform Rating, Price Target is $23	18/10/23	MT
Mizuho Adjusts Price Target on Vigil Neuroscience to $13 From $15, Keeps Buy Rating	10/08/23	MT
Mizuho Initiates Vigil Neuroscience at Buy With $15 Price Target	31/03/23	MT
Morgan Stanley Adjusts Vigil Neuroscience Price Target to $13 From $12, Maintains Equal Weight Rating	27/03/23	MT
Morgan Stanley Adjusts Price Target on Vigil Neuroscience to $12 From $11, Maintains Equalweight Rating	14/11/22	MT
Guggenheim Trims Price Target on Vigil Neuroscience to $19 From $22, Maintains Buy Rating	11/11/22	MT
Wedbush Trims Vigil Neuroscience's Price Target to $23 From $24 on Higher Share Count, Keeps Outperform Rating	11/11/22	MT
Wedbush Starts Vigil Neuroscience at Outperform With $19 Price Target	16/09/22	MT
HC Wainwright Starts Vigil Neuroscience at Buy With $24 Price Target	29/08/22	MT
Morgan Stanley Lowers Vigil Neuroscience's Price Target to $11 From $17, Maintains Equalweight Rating	17/05/22	MT
Morgan Stanley Starts Vigil Neuroscience at Equalweight With $17 Price Target	01/02/22	MT
Guggenheim Starts Vigil Neuroscience at Buy With $23 Price Target	01/02/22	MT
Stifel Starts Vigil Neuroscience at Buy With $24 Price Target	01/02/22	MT
Jefferies Starts Vigil Neuroscience at Buy With $20 Price Target	01/02/22	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

+39.41% on our US portfolio vs. 25.67% on the S&P 500 net Total Return

Replicate our performance

fermer